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Oral Toxicity of 1,1-Dichloroethylene
in the Rat: Effects of Sex, Age,
and Fasting
by Melvin E. Andersen* and Lawrence J. Jenkins Jr.*
Mortality curves for groups of fasted male rats treated with single, oral doses of 1,1-dichloroethylene
(1,l-DCE, vinylidene chloride) were not monotonically increasing sigmoids, but were complex with
maxima or extended plateaus in the region of dose between 100 and 700 mg of 1,1-DCE/kg. The exact
shape was a function ofthe size (age) ofthe rat used. When groups ofrats ofvarious sizes were dosed with
50 mg/kg, mortality and hepatotoxicity were greatest for those groups whose average weight was between
100 and 150 g. Smaller and larger male rats were less susceptible to 1,1-DCE intoxication. The toxicity of
1,1-DCE was less severe in female rats and there was nosignificanteffect ofrat size on 1,1-DCE toxicity in
females. In rats ofboth sexes the dose dependence ofthe hepatotoxic response was complex, possessing a
threshold level, a region of precipitous increase, and a plateau, where larger doses were ineffectiv,e in
increasing hepatotoxicity. The threshold in male rats of 100-150 g occurred near 50 mg/kg, and for
females it was closer to 100 mg/kg. Considered in their entirety these data suggest that 1,1-DCE is
metabolized to a toxic intermediate via some saturable pathway. Based on the effects ofpretreatment with
microsomal enzyme inhibitors and activators on 1,1-DCE toxicity in rats ofvarious sizes, it appears that
there are at least two microsomal reactions involved in 1,1-DCE metabolism.
Introduction
The hepatotoxicity (1, 2) and nephrotoxicity (3)
of single, oral doses of 1, 1-dichloroethylene
(1,l-DCE, vinylidene chloride) in the rat have been
previously described. In fasted male rats weighing
between 300 and 500 g the acute oral LD50 was 1550
mg of I,l-DCE/kg (1). However, l,I-DCE has
been found to be much more toxic to immature male
rats and dose mortality curves for these smaller
animals were complex with extended plateaus or
even maxima. A preliminary report of these studies
has appeared (4). This present study describes the
acute oral toxicity of l,l-DCE in male and female
rats of various sizes and is a part of an extensive
reinvestigation of the oral toxicity of this chlori-
nated ethylene monomer and ofthose factors which
alter its toxicity.
Materials and Methods
Rats
The Holtzman HOT: (SD)BR rats used in these
*Naval Medical Research Institute, Toxicology Detachment,
Wright-Patterson Air Force Base, Ohio 45433.
experiments were housed singly in wire mesh cages
in an air-conditioned room and were provided
commercial rat chow and tap water ad libitium. Rats
were fasted by withdrawing food at 4:00 PM the day
previous to treatment, dosed between 8:00 AM and
10:00 AM the next morning and then allowed free
access to food 2-4 hr after dosing.
1,1-Dichloroethylene
Gas chromatographic analysis of the stock
I-DCE obtained from K & K Laboratories,
Plainview, N. Y. showed it to contain 98.5%
1I,-DCE, 0.80% trans-1,2-1DCE and 0.55%
cis-1,2-DCE. It was dissolved in corn oil and ad-
ministered in doses adjusted to a total volume of 2
ml/kg. Control rats received 2 ml of corn oil/kg. In
experiments to determine mortality caused by vari-
ous doses of l,l-DCE rats were observed for 14
days after dosing, even though over80% ofthe mor-
taiitv was observed in the first 24 hr. Plasma en-
.ynme .ictivities were determined at various times
after- or-al doses of l,l-DCE. Rats were killed with
an intraperitoneal injection of a lethal dose of
sodiu Lm pentobarbital. the abdomen was rapidly
December 1977 157opened, and the rats were exsanguinated by with-
drawing blood from the portal vein. Plasma,was
prepared from this blood as previously described
(5).
Biochemical Determinations
The assay procedures used to determine plasma
enzymatic activities of lactic dehydrogenase (LD:
L-lactate: NAD oxido-reductase, EC 1.1.1.27),
alanine transaminase (AlT; L-alanine: 2-oxoglu-
tarate aminotransferase, EC 2.6.1.2), asparate
transaminase (AsT; L-aspartate:2-oxoglutarate
aminotransferase, EC 2.6.1.1) and D-sorbitol de-
hydrogenase (SDH; L-iditol:NAD oxiodoreduc-
tase, EC 1.1.1.14) have been previously described
(3).
Results
Fed-Fasted Differences
Hepatotoxicity, measured as increases in plasma
transaminase activities, caused by inhalation of
1,1-DCE, has been shown to be greater in fasted
rats than in fed rats (6, 7). When large, mature, male
rats were intubated with 400 mg of 1,l-DCE/kg, the
hepatotoxic response measured as increased
plasma aspartate transaminase (Fig. 1) was 4 to 5
times greater in the fasted rats. Studies on the time
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FIGURE 1. Effect of fasting on increases in plasma aspartate
transaminase activity following intubation of a single, oral
dose of400 mg of 1,l-dichloroethylene/kg. Plasma aspartate
transaminase activity was measured at various times after
dosing male rats with 400 mg of 1,1-DCE/kg. The hatched
columns are data from rats fasted for 18 hr before dosing; the
filled columns, data from rats allowed food ad libitum before
challenge. Data are means + SE for 24 rats.
course of the increases in plasma enzyme activities
at various times after a single, oral dose of l,1-DCE
in these fasted, large rats showed that the increases
at 8 hr or 24 hr were greater than at any other times
and were equivalent. As a matter of convenience,
plasma enzyme activities in all subsequent studies
were measured at 24 hr after 1,1-DCE intubation
and all studies were done with fasted rats.
Dose Mortality Curves in Rats of
Various Sizes
An attempt was made to determine the oral LD50
of 1,l-DCE in rats of various sizes. The mortality
curve for large male rats (395 ±+ lg) increased
monotonically from 0 to 100% mortality with doses
from 800 to 2000 mg of l,l-DCE/kg, giving esti-
mates ofthe acute, oral LD50 which agreed with the
earlier report of Jenkins et al. (1). However, even
with these larger rats, mortality was consistently
observed at doses as low as 50 mg of l,l-DCE/kg
(Fig. 2). With groups of male rats weighing 224 + 1
g mortality following doses between 50 and 800 mg
of l,1-DCE/kg varied between 10 and 33%. In
weanling rats weighing73 ± 1 g, acurve with a max-
imum of 100% (10/10) mortality at a dose of 300
mg/kg was obtained. Percent mortality then de-
creased as dose was increased up to 800 mg/kg (Fig.
2). Dose-mortality curves with maxima or ex-
tended plateaus between 100 and 700 mg of
1,1-DCE were seen repeatedly in male rats of all
sizes. It proved impossible therefore to calculate
unambiguously the LD50 of 1,1-DCE in these
younger rats.
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FIGURE 2. Dose-mortality curves for administration of single,
oral doses of I,l-DCE dissolved in corn oil to fasted male
rats ofvarious sizes: (e) mortality in groups ofsix rats [the 30
rats represented by these five points weighed 395 + 11 g
(mean ± standard error)]; (A) mortality in groups of 10 rats
for40weanling rats weighing73 ± 1 g; (a) mortality in groups
of 10 rats [the 4D rats weighed 224 ± I g].
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Various Sizes
Increased mortality in groups ofyounger rats was
accompanied by increased hepatotoxicity of
l,l-DCE in these animals. Thus, when two groups
of rats, one whose average weight was approxi-
mately 300 g, the second whose average weight was
approximately 200 g were challenged with a dose of
25 mg of 1,l-DCE/kg, the smaller rats had in-
creased plasma transaminase levels at 24 hr after
dosing while the larger rats were unaffected (Fig.
3). To determine the hepatotoxicity of a dose of 50
mg of I,1-DCE/kg in male rats ofdifferent sizes, 10
groups of rats were used. The rats in each group
were the same age and at the time of their delivery
from the breeder the individual weights of the rats
in any one group were within a 10 g range. Approx-
imately half the rats in each group were dosed with
50 mg of 1,1-DCE/kg and the remainder with corn
oil. All rats were sacrificed at 24 hr after dosing.
Mortality within the first 24 hr and plasma enzyme
activities at 24 hr were greatest in those rats weigh-
ing between 130 and 160 g (Table 1). Mortality in
the group weighing 138 + 2 g was 5/6. The LD50 of
1,1-DCE in rats of this weight must be less than 50
mg/kg, smaller by a factor of 30 than the oral LD50
in large rats. (A more detailed analysis of a dose
mortality curve for rats of this weight might show a
mortality maxima somewhere above 50 mg/kg.) The
magnitude ofthe increases in plasma enzymatic ac-
tivities paralleled mortality in these various groups.
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FIGURE 3. Hepatotoxicity of a single, oral dose of 25 mg of
1 ,1-DCE/kg in male rats of two different sizes. The solid
columns represent data from fasted male rats challenged with
25 mg of 1,1-DCE/kg; the hatched columns represent data
from control rats given 2 ml ofcorn oil/kg. Data are mean ±+
SE ofsix rats. Columns are centered on the average weight of
six rats in that particular treatment group.
Table 1. Plasma enzyme activities in fasted, male rats of various sizes 24 hr after a single oral dose of 50 mg of
1,l-dichloroethylene/kg dissolved in corn oil.
Weight, AsT, AIT, SDH, LD,
g Treatment Mortality na Aumole/min-1.b ,Amole/min-1.b ,Amole/min-1.8 uimole/min-1.b
83 + 6 1,1-DCE 0/6 5 2147 ± 1593 289 ± 152 380 ± 239 746 ± 544
92 8 Control 0/5 5 153 45 64 34 7 1.8 194 75
138 + 2 1,l-DCE 5/6 1 8300 680 160 14200
137 3 Control 0/5 5 141 62 26 3 10 4 194 75
155 + 3 1,l-DCE 3/6 3 3767 ± 1612 680 ± 289 900 ± 372 1122 ± 731
153 ±3 Control 0/5 5 58 8 29 5 4.6 2.0 87 9.3
180 + 2 1,l-DCE 0/6 6 919 ± 446 287 ± 145 7.5 ± 4.8 461 ± 300
179 4 Control 0/5 4 57 ± 9 22 3 7.75 ±3.1 85 8
197 ± 6 1,l-DCE 0/6 6 738 ± 211 521 ± 127 287 ± 102 149 ± 35
231 10 Control 1/5 4 45 ± 5 15 2 3.5 2 56.5 7
221 ± 3 l,l-DCE 0/5 5 1045 ± 600 255 ± 114 291 ± 183 148 ± 53
217 10 Control 0/5 5 46 5 23 5 9 ± 2 134 56
237 6 ,11-DCE 0/6 6 227 81 107 36 66 ± 25 91± 10
230 4 Control 0/5 5 44 3 19 3 10 ± 3 97 22
255 5 l,l-DCE 1/4 3 47 17 16 ± 0 95 2 117 ± 49
252 8 Control 0/4 4 39 5 24 ± 3 7 2 86 ± 17
275 8 l,l-DCE 0/6 6 69 13 63 ± 31 20 6 96 ± 24
271 10 Control 0/4 4 48 6 17 ± 2 6 1 75 ± 15
282 +5 l1-DCE 1/6 5 71 11 29 ± 4 20 6 96 ± 24
218 8 Control 0/4 4 49 4 19 ±+4 7 2 93 ± 11
an is the number ofrats used in each group in the determination ofenzyme activities. (It is in fact the numberofsurvivors
at 24 hr.)
bAsT, aspartate transaminase; AIT, alanine transaminase; SDH, D-sorbitol dehydrogenase; and LD, lactic dehy-
drogenase. All activities are given as ,umoles product/min/liter of plasma (International Units/I.) at 30°C and data are
means ± SE.
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Immature Male Rats
Male rats weighing between 90 and 120 g were
dosed in groups of six with various doses of
l,1-DCE between 0 and 200 mg/kg. Survivors were
sacrificed at 24 hr after 1,1-DCE administration.
Plasma transaminase activities from these rats
(Table 2) showed a marked increase as dose was
raised from 25 to 50 mg/kg, but further increases in
dose had little or no effect on these activities.
Plasma lactic dehydrogenase activity, however,
doubled between 50 and 125 mg/kg, but was con-
stant thereafter.
Retention of 1,1-DCE Following a
Single Oral Dose
Studies were conducted to determine the amount
of 1,1-DCE off-gassed by rats after an oral dose of
this chemical. Individual rats dosed with various
amounts of 1,1-DCE were placed into a 31-liter
flow-thru chamber (8), served with compressed air
at a constant flow rate. Chamber exhaust was di-
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FIGURE 4. Relationship between retention of 1,1-dichloroethy-
lene by the rat and the initial, oral dose. Data are means + SE
of 3-6 rats. Rats were dosed with 1,1-DCE then housed in
flow-thru chambers. The exhaust from the chamberwas con-
tinuously analyzed for 1,1-DCE by infrared spec-
trophotometry. The dotted line is that line expected ifall the
intubated 1,1-DCE were retained. The weights of the rats
used for this study varied between 100 and 150 g.
Table 2. Plasma enzyme activities in fasted male rats weighing approximately 100 g 24 hr after intubation ofvarious doses of
1,1-dichloroethylene dissolved in corn oil.
Weight, Dose, AsT, AIT, SDH, LD,
g n Mortality mg/kg ,umole/min-l.a ,hmole/min-l.a iAmole/min-l.a iLmole/min-l.a
104 + 4 6 0/6 0 59 t 6 24 ± 2 11 ± 1 110 t 25
106 ± 3 6 0/6 12.5 69 ± 7 23 ± 3 9± 4 94 ± 28
103 ± 5 6 0/6 25 210 ± 45 52 ± 9 65 ± 21 138 ± 48
106 ± 2 6 0/6 50 6929 t 746 852 t 116 1296 t 236 8987 t 2291
101 t 1 6 4/6 75 4992 t 176 1040 t 112 1707 ± 106 9208 t 1480
100 t 6 6 4/6 100 5848 t 3896 936 ± 648 1135 ± 308 6528 t 4224
101 ± 4 6 2/6 125 8460 t 526 1340 ± 158 1328 t 166 19760 t 1918
105 t 2 6 4/6 150 6048 t 832 976 t 592 1311 ± 431 20720 ± 6480
108 t 5 6 4/6 200 6649 t 200 1088 t 0 1285 t 229 15120 t 3440
aAsT, aspartate transaminase; AIT, alanine transaminase; SDH, D-sorbitol dehydrogenase; and LD, lactic dehy-
drogenase. All activities are given as ,umoles product/min/liter ofplasma (International Units/1) at 30°C and data are means
± SE.
rected through an infrared spectrophotometer
whose monochromator was set at an absorption
band of the 1,1-DCE (9.1 ,t). Integration of the ab-
sorbance output of the infrared spectrophotometer
yielded a number proportional to the total amount
of 1,1-DCE off-gassed, excreted or passed through
the skin. The amount of 1,1-DCE retained was the
difference between the total dose and the total
amount excreted by these various routes. The
amount of 1,1-DCE retained by immature, fasted
male rats increased linearly up to atotal dose of 100
mg/kg and then levelled off(Fig. 4).
Sex Differences in 1,1-DCE Toxicity
Investigations ofthe toxicity ofsingle, oral doses
of 1,1-DCE were also conducted using female rats.
The time course of the hepatotoxic response to
1,1-DCE was essentially the same in the female rat
(Fig. 5) as in the male rat. However, females were
much less susceptible to 1,1-DCE intoxication.
When female rats of various sizes were challenged
with 50 mg of 1,1-DCE/kg, no significant differ-
ences were observed in plasma transaminase levels
between treated and control groups (Fig. 6).
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FIGURE 5. Time course of increases in plasma transaminase ac-
tivities following intubation of female rats with 400 mg of
l,l-DCE/kg. Data are means + SE for four rats. AsT is
aspartate transaminase; AIT, alanine transaminase.
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FIGURE 6. Plasma alanine transaminase activities in fasted
female rats of various sizes 24 hr after a single, oral dose of50
mg of ,1-dichloroethylene/kg. The data points are means +
SE of five rats. They are located in a position along the ordi-
nate corresponding to the average weight of the rats in the
group. In no case was the standard error of the mean of the
rat weight of a group greater than 5 g.
Dose Dependence of 1,1-DCE
Toxicity in Female Rats
Female rats weighing 200-250 g were dosed in
groups of six with various doses of l,1-DCE be-
tween 0 and 200 mg/kg. All of these female rats
survived the first 24 hr and were then sacrificed. A
large increase in plasma transaminase activities was
observed as dose was increased from 100 to 150
mg/kg, while further increases in dose actually pro-
duced plasma enzyme activities lower than those
observed with a dose of 150 mg/kg (Fig. 7).
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FIGURE 7. Plasma enzyme activities in fasted female rats 24 hr
after intubation of various doses of I,1-dichloroethylene.
Data are means SE for four rats. Weight range ofthe rats
used was 200-250 g.
Discussion
The dose dependence of the hepatotoxicity of
single, oral doses of I,l-DCE measured as in-
creases in plasma transaminase levels, was complex
and appeared to have a threshold. The transition
from a dose of 1,1-DCE whose effect was relatively
benign to one whose effect was frank, extensive
hepatic injury occurred abruptly over a narrow
range of dose. In small male rats the threshold oc-
curred near a dose of 25 mg/kg. The hepatotoxicity
of bromobenzene also exhibits threshold effects.
This compound is metabolized to 3,4-bromoben-
zene oxide, a reactive intermediate, which can
either react preferentially and innocuously with
glutathione (GSH) or when cellular GSH is ex-
hausted with vital cellular constituents to produce
its toxic effects (9). Threshold effects are man-
ifested at that point where GSH becomes seriously
depleted, after which only small increments of in-
gested bromobenzene produce extensive toxicity
(10). The hepatotoxicity of inhaled 1,1-DCE can
also be increased by deplktion of GSH either by
fasting or by pretreating rats with diethylmaleate (6,
7). Similarly, the hepatotoxicity of orally adminis-
tered 1,1-DCE is also enhanced by pretreating rats
with diethylmaleate (11) or by fasting, as shown
herein.
The mutagenicity of 1,1-DCE and of vinyl
chloride monomer (VCM) were greatly enhanced
when the incubation media was supplemented with
microsomal protein, 02 and NADPH regenerating
system, indicating that these compounds were mi-
crosomally converted to more toxic metabolites
(12, 13). Vinyl chloride' is metabolized by the rat via
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halation of VCM and 1,l-DCE reduced 1,1-DCE
hepatotoxicity (15, 16). The dose dependence ofthe
inhibition of 1,1-DCE toxicity by VCM suggested a
competitive interaction. Thus VCM and 1,1-DCE
appear to be metabolized in vivo in similar if not
identical reactions. Indeed, the amount of 1,1-DCE
retained after a single oral dose becomes constant at
challenge doses of greater than 100 mg/kg (Fig. 4),
suggesting that the metabolism of 1,l-DCE, just as
that of VCM, occurs through a saturable pathway.
In female rats, the threshold dose of 1,1-DCE
was approximately 100 mg/kg (Fig. 7) and females
were much less susceptible to l,1-DCE toxicity
than were males. Microsomal oxidation ofa variety
ofcompounds is greater in male than in female rats
(17), and these observed toxicity differences in male
and female rats are also consistent with the assump-
tion that 1,1-DCE is metabolized to a more toxic
compound. Furthermore, the activity of a number
ofrat microsomal oxidases reach a maximum in the
male rat at 30-40 days (18). Growth curves of the
Holtzman rats used in this study showed that rats of
this age would weigh 100-150 g, the weight of the
rats most susceptible to 1,1-DCE intoxication
(Table 1).
The data in this paper describing the oral toxicity
of l,1-DCE are consistent in suggesting that
1,1-DCE must be metabolized in vivo by some mi-
crosomal enzyme activity to a more toxic inter-
mediate. Based on the dose dependence of the
hepatotoxic response in male and female rats, the
retention of 1,1-DCE after oral dosing and the un-
usual shape ofthe mortality curves, this microsomal
reaction converting 1,1-DCE to a more toxic
chemical(s) would appear to be saturable and prob-
ably inhibitible at higher 1,1-DCE concentrations.
While similar effects have not been reported in
studies of the inhalation toxicity of 1,1-DCE, they
might have been obscured by the custom of con-
ducting exposures for 4 hr. In the investigations of
the off-gassing of 1,1-DCE the major portion ofthe
off-gassing occurred between 0.5 and 1.5 hr. Inhala-
tion studies to corroborate these present results
would have to focus on 1,l-DCE toxicity after
short-term (1/2 to 2 hr) exposures. Such work is
presently under way in our laboratory.
Jenkins et al. (1) and Reynolds et al. (19) have
reported that phenobarbital pretreatment, which in-
creased microsomal oxidase activities, protected
rats from the hepatotoxic effects of 1,1-DCE. While
this at first glance appears to contradict the conclu-
sions of this study, other work on the effect of mi-
crosomal inhibitors and activators has clarified this
difficulty. Several pretreatment regimens, all of
which inhibit Type II microsomal activities, have
been shown to block the hepatotoxicity of 1,1-DCE
(4). These are: (1) pyrazole (320 mg/kg); (2) amino-
triazole (200 mg/kg); (3) carbon tetrachloride (1500
mg/kg, 1 hr prior to 1,l-DCE or 375 mg/kg at the
same time as 1,l-DCE). Phenobarbital pretreat-
ment protects smaller rats but is increasingly less
effective as rat weight increases. Conversely, pre-
treatment with SKF 525-A markedly exacerbates
1,1-DCE toxicity in older, mature rats but does not
affect its toxicity in smaller rats (4).
To accommodate these observations of the ef-
fects of inducers and inhibitors of microsomal en-
zyme activities on l,l-DCE toxicity with a re-
quirement that metabolic activation occur before
the toxicity of 1,1-DCE can be expressed at least 2
microsomal reactions must be hypothesized. These
two reactions, designated by the numbers 1 and 2,
are shown in the metabolic scheme for 1,11-DCE in
Figure 8. The first microsomal enzymatic activity
(reaction 1) converts 1,1-DCE to a toxic inter-
mediate. It is that activity blocked by pretreatments
with CCL4, pyrazole or aminotriazole. The second
microsomal activity (reaction 2), which is absent or
present at only low levels in younger rats, is in-
duced by phenobarbital pretreatment in young-rats
and inhibited by pretreatment with SKF 525-A in
older rats. It is responsible for converting the toxic
metabolite (or a toxic rearrangement product of a
metabolite) to less toxic materials.
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FIGURE 8. Suggested scheme for the metabolism of
1,1-dichloroethylene by the rat.
Based on analogy with the proposed metabolism
of other clorinated ethylenes (20), metabolism of
1,1-DCE has been suggested to produce an epoxide
(13, 19). Attempts to synthesize the epoxide of
1,1-DCE have been unsuccessful (13, 21), but from
the nature of the reaction products, primarily
chloracetylchloride, the epoxide has been pre-
sumed to be a transient, unstable intermediate.
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GSH by glutathione transferase (22, 23) hydrolyzed
by epoxide hydratase (24, 25) or could react with
other nucleophiles. If the epoxide rearranged to an
acid chloride, it could react with H20 and any of a
variety ofnucleophiles including GSH. Glutathione
depletion, by pretreatment with diethyl maleate or
by fasting then would decrease the capacity of the
rat to detoxify the intermediate(s). Careful, detailed
in vitro studies ofthe biotransformation of 1,1-DCE
are necessary to fully describe the nature of the
enzymic activities and the various suspected
metabolites of l,1-DCE.
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